Activation of Protein Kinase A (PKA) signaling mitigates congenital hyperinsulinism associated hypoglycemia in the Sur1-/- mouse model.
There is a significant unmet need for a safe and effective therapy for the treatment of children with congenital hyperinsulinism. We hypothesized that amplification of the glucagon signaling pathway could ameliorate hyperinsulinism associated hypoglycemia. In order to test this we evaluated the effe...
Main Authors: | Mangala M Soundarapandian, Christine A Juliana, Jinghua Chai, Patrick A Haslett, Kevin Fitzgerald, Diva D De León |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0236892 |
Similar Items
-
NEUROLOGICAL PAROXYSMAL DISORDERS IN CHILDREN WITH HYPOGLYCEMIA IN CONGENITAL HYPERINSULINISM: POLYMORPHISM OF CLINICAL IMPLICATIONS
by: I. O. Shchederkina, et al.
Published: (2016-05-01) -
Congenital hyperinsulinism
by: Indrė Petraitienė, et al.
Published: (2014-01-01) -
Extreme caution on the use of sirolimus for the congenital hyperinsulinism in infancy patient
by: Indraneel Banerjee, et al.
Published: (2017-04-01) -
Congenital intrahepatic portocaval shunts and hypoglycemia due to secondary hyperinsulinism: a case report and review of the literature
by: Alexander Weigert, et al.
Published: (2018-11-01) -
Neonatal congenital hyperinsulinism in Indonesia
by: I.Made Arimbawa, et al.
Published: (2021-01-01)